TG Therapeutics Statistics
Total Valuation
TGTX has a market cap or net worth of $3.25 billion. The enterprise value is $3.14 billion.
| Market Cap | 3.25B |
| Enterprise Value | 3.14B |
Important Dates
The next estimated earnings date is Tuesday, July 30, 2024, before market open.
| Earnings Date | Jul 30, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
TGTX has 154.54 million shares outstanding. The number of shares has increased by 4.20% in one year.
| Shares Outstanding | 154.54M |
| Shares Change (YoY) | +4.20% |
| Shares Change (QoQ) | -6.38% |
| Owned by Insiders (%) | 9.55% |
| Owned by Institutions (%) | 59.51% |
| Float | 133.17M |
Valuation Ratios
The trailing PE ratio is 95.45 and the forward PE ratio is 140.85.
| PE Ratio | 95.45 |
| Forward PE | 140.85 |
| PS Ratio | 11.22 |
| Forward PS | 14.37 |
| PB Ratio | 20.27 |
| P/FCF Ratio | 160.01 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 58.40, with an EV/FCF ratio of 155.04.
| EV / Earnings | 76.33 |
| EV / Sales | 10.87 |
| EV / EBITDA | 58.40 |
| EV / EBIT | 58.59 |
| EV / FCF | 155.04 |
Financial Position
The company has a current ratio of 3.62, with a Debt / Equity ratio of 0.69.
| Current Ratio | 3.62 |
| Quick Ratio | 2.77 |
| Debt / Equity | 0.69 |
| Debt / EBITDA | 2.05 |
| Debt / FCF | 5.44 |
| Interest Coverage | 4.45 |
Financial Efficiency
Return on equity (ROE) is 31.30% and return on invested capital (ROIC) is 17.70%.
| Return on Equity (ROE) | 31.30% |
| Return on Assets (ROA) | 13.10% |
| Return on Capital (ROIC) | 17.70% |
| Revenue Per Employee | $1.10M |
| Profits Per Employee | $156,049 |
| Employee Count | 264 |
| Asset Turnover | 0.92 |
| Inventory Turnover | 0.36 |
Taxes
In the past 12 months, TGTX has paid $419,000 in taxes.
| Income Tax | 419,000 |
| Effective Tax Rate | 1.01% |
Stock Price Statistics
The stock price has decreased by -1.13% in the last 52 weeks. The beta is 2.23, so TGTX's price volatility has been higher than the market average.
| Beta (5Y) | 2.23 |
| 52-Week Price Change | -1.13% |
| 50-Day Moving Average | 17.91 |
| 200-Day Moving Average | 14.93 |
| Relative Strength Index (RSI) | 63.05 |
| Average Volume (20 Days) | 2,868,665 |
Short Selling Information
The latest short interest is 32.70 million, so 21.16% of the outstanding shares have been sold short.
| Short Interest | 32.70M |
| Short Previous Month | 33.56M |
| Short % of Shares Out | 21.16% |
| Short % of Float | 24.55% |
| Short Ratio (days to cover) | 13.34 |
Income Statement
In the last 12 months, TGTX had revenue of $289.33 million and earned $41.20 million in profits. Earnings per share was $0.22.
| Revenue | 289.33M |
| Gross Profit | 270.62M |
| Operating Income | 48.36M |
| Pretax Income | 41.62M |
| Net Income | 41.20M |
| EBITDA | 53.85M |
| EBIT | 53.68M |
| Earnings Per Share (EPS) | $0.22 |
Balance Sheet
The company has $211.07 million in cash and $110.29 million in debt, giving a net cash position of $100.79 million or $0.65 per share.
| Cash & Cash Equivalents | 211.07M |
| Total Debt | 110.29M |
| Net Cash | 100.79M |
| Net Cash Per Share | $0.65 |
| Equity (Book Value) | 160.11M |
| Book Value Per Share | 1.04 |
| Working Capital | 260.90M |
Cash Flow
| Operating Cash Flow | 20.28M |
| Capital Expenditures | n/a |
| Free Cash Flow | 20.28M |
| FCF Per Share | $0.14 |
Margins
Gross margin is 93.53%, with operating and profit margins of 16.71% and 14.24%.
| Gross Margin | 93.53% |
| Operating Margin | 16.71% |
| Pretax Margin | 14.38% |
| Profit Margin | 14.24% |
| EBITDA Margin | 18.61% |
| EBIT Margin | 18.55% |
| FCF Margin | 7.01% |
Dividends & Yields
TGTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.20% |
| Shareholder Yield | -4.20% |
| Earnings Yield | 1.27% |
| FCF Yield | 0.62% |
Analyst Forecast
The average price target for TGTX is $31.20, which is 48.57% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $31.20 |
| Price Target Difference | 48.57% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 41.38% |
| EPS Growth Forecast (5Y) | 112.63% |
Stock Splits
The last stock split was on April 30, 2012. It was a reverse split with a ratio of 100:5625.
| Last Split Date | Apr 30, 2012 |
| Split Type | Reverse |
| Split Ratio | 100:5625 |
Scores
TGTX has an Altman Z-Score of 5.5 and a Piotroski F-Score of 6.
| Altman Z-Score | 5.5 |
| Piotroski F-Score | 6 |